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ABSTRACT 
Objective: Non-steroidal anti-inflammatory agents (NSAIDs) continue to be one of the most widely used groups of therapeutic agents. QSAR 
(quantitative structure-activity relationship) approach is a very useful and widespread technique for drug design. 3D QSAR facilitates evaluation of 
three-dimensional molecular fields around molecules and generates a relationship of these fields' values with the activity. 
Methods: 3D QSAR study was performed on selected twenty-four compounds from synthesized indole derivatives using the stepwise variable 
selection k-nearest neighbor (kNN) molecular field analysis approach for indicating the contribution of the steric and electronic field for activity. 
The docking study was performed to further confirm the binding affinity of synthesized molecules (ligands) to COX-2 enzyme as well as to study 
binding nature. 
Results: Statistically significant model was generated using VLife Molecular Design Suite 3.5 software with cross-validated correlation coefficient q2 
of 0.9461 and high predictive correlation coefficient (Pred_r2) of 0.8782 indicating that the model is robust. The results of docking study suggest 
that the synthesized compounds have a comparable binding affinity with the COX-2 enzyme.  
Conclusion: The present study may prove to be helpful in the development and optimization of existing indole derivatives as anti-inflammatory 
agents with selective COX-2 inhibition. 
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Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit 
cyclooxygenase (COX), the enzyme responsible for the conversion of 
arachidonic acid to prostaglandins. COX exists in 2 isoforms. COX-1 is a 
ubiquitous constitutive isozyme producing prostaglandins responsible 
for homeostatic functions such as maintenance of gastrointestinal (GI) 
mucosal integrity. COX-2 is largely a cytokine-induced isozyme 
producing prostaglandins that mediate pain and inflammation [1]. 
NSAIDs inhibit both COX-1 and COX-2 to varying degrees. Thus, the 
therapeutic effects of conventional NSAIDs are derived from inhibition 
of COX-2, while the adverse effects of these agents, particularly in the 
upper GI tract, arise from inhibition of COX-1 activity [2-3]. Much 
recent effort thus has been made to produce selective inhibitors of 
COX-2 in the belief that these will lack the gastrointestinal damaging 
effects of traditional NSAIDs [4-6]. Diarylheterocycle class of 
compounds has been investigated extensively as COX-2 inhibitors. 
Literature survey revealed that indole derivatives, pyrazoline 
derivatives, and pyrimidine derivatives independently possess good 
anti-inflammatory, analgesic activity and selective COX-2 inhibitory 
effects [7-12]. Hence we tried to obtain greater selectivity for COX-2 
enzymes with the use of the indole nucleus and other structural 
features of different COX-2 inhibitors in the designed molecules. Thus 
the concept of chemical hybridization of the indole nucleus with 
pyrazoline and pyrimidine was attempted.  
Three series of the target molecules were synthesized and subjected 
to preliminary pharmacological evaluation for anti-inflammatory 
and analgesic activity by using models like carrageenin-induced rat 
paw edema method and acetic acid-induced writhing in mice 
respectively. The compounds were also screened for acute 
ulcerogenicity by using Wistar rats. The compounds viz. IA7, IA9, 
IA11, IA12, IB3, IB7, IB12, IIA2, IIA3, IIA4, IIA5, IIA10, IIB2, IIB3, 
IIB4, IIB5, IIB7, IIIA4, IIIA10, IIIA11, IIIA17, IIIB10, IIIB11, IIIB17 
showing comparable anti-inflammatory, analgesic activities with 
less ulceration were subjected to in vitro COX inhibition assays using 
Celecoxib as the reference [13].  
The computer-aided prediction of biological activity in relation to 
the chemical structure of a compound is now a commonly used 
technique in drug discovery. Computational chemistry represents 
molecular structures as a numerical model and simulates their 
behavior with the equations of quantum and classical physics. 
Available programs enable scientists to easily generate and present 
molecular data including geometries, associated properties 
(electronic, spectroscopic and bulk). The usual paradigm for 
displaying and manipulating these data is a table in which 
compounds are defined by individual rows and molecular properties 
(or descriptors) are defined by the associated columns [14-17].  
Three-dimensional quantitative structure-activity relationship (3D 
QSAR) facilitates evaluation of three-dimensional molecular fields 
around molecules and generates a relationship of these fields' values 
with the activity. The k-nearest neighbor (kNN) method is one of the 
methods for generating a relationship between activity and 
molecular field and provides an interpretation of results thus 
providing clues for designing new molecules. kNN-MFA (Molecular 
Field Analysis) requires suitable alignment of a set of molecules. 
This is followed by generation of a common rectangular grid around 
the molecules. The steric and electrostatic energies are computed at 
the lattice points of the grid using methyl probe of charge+1. These 
interaction energy values at the grid points are considered for 
relationship generation using kNN method.  
The kNN technique is a conceptually simple approach to pattern 
recognition problems. In this method, an unknown pattern is 
classified according to the majority of the class memberships of its k 
nearest neighbors in the training set. The nearness is measured by 
an appropriate distance metric (e. g. molecular similarity measure 
calculated using field interactions of molecular structures). The 
standard kNN method is implemented as follows: (i) calculate 
distances between an unknown object (u) and all the objects in the 
training set (ii) select k objects from the training set most similar to 
object (u), according to the calculated distances (iii) classify object 
(u) with the group to which a majority of the k objects belong. An 
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optimal k value is selected by the optimization through the 
classification of a test set of samples or by the leave-one-out cross-
validation. The variables and optimal k values are chosen using 
different variable selection methods like Simulated Annealing 
variable selection method.  
Drug exerts its biological activity by binding to the pocket of 
receptor molecule usually protein. In their binding conformations, 
the molecules exhibit geometric and chemical complementarily, 
both of which are essential for successful drug activity. The 
computational process of searching for a ligand that is able to fit 
both geometrically and energetically into the binding site of a 
protein is called molecular docking. 
Molecular docking helps in studying drug/ligand or receptor/protein 
interactions by identifying the suitable active sites in the protein, 
obtaining the best geometry of ligand-receptor complex and calculating 
the energy of interaction for different ligands to design more effective 
ligands. The target or receptor is either experimentally known or 
theoretically generated through knowledge-based protein modeling or 
homology modeling. The molecular docking tool has been developed to 
obtain a preferred geometry of interaction of ligand-receptor complexes 
having minimum interaction energy based on different scoring functions 
viz. only electrostatics, the sum of steric and electrostatic and dock score. 
This utility allows one to screen a set of compounds for lead 
optimization. Genetic algorithm (GA), Piecewise Linear Pairwise 
Potential (PLP) and Grid algorithms are used to minimize the interaction 
energy between ligand-receptor.  
In the present research work, a data set of twenty-four molecules 
showing comparable COX 2 inhibitory activity was subjected to 3D 
QSAR analyses, in search of newer and potent anti-inflammatory 
agents with selective COX-2 inhibition. Statistically, significant 
models were generated, and the most robust models for 3D QSAR 
was obtained using stepwise variable selection kNN-MFA approach 
using V-Life Molecular Design Suite software version 3.5.  
MATERIALS AND METHODS  
Optimization of molecules’ structures  
A data set of twenty-four molecules showing comparable COX 2 
inhibitory activity measured was chosen for the present 3D QSAR 
study as shown in table 1. The biological activity was expressed as 
IC50 values measured on COX-2 enzyme. 
  






S. No. Compd R1 R2 R3 
1 IA7  5-(4-methoxyphenyl)-1-phenylpyrazoline 4-chlorophenyl H 
2 IA9  1,5-diphenylpyrazoline 4-methoxyphenyl H 
3 IA11  5-(4-methoxyphenyl)-1-phenylpyrazoline 4-methoxyphenyl H 
4 IA12  5-(4-dimethyaminophenyl)-1-
phenylpyrazoline 
4-methoxyphenyl H 
5 IB3  4(4-methoxyphenyl)pyrimidin-2-amine Phenyl Phenyl 
6 IB7  4(4-methoxyphenyl)pyrimidin-2-amine 4-chlorophenyl Phenyl 
7 IB12  4(4-(dimethylamino)phenyl)pyrimidin-2-
amine 
4-methoxyphenyl Phenyl 
8 IIA2 methylsulfonyl 5-(4-chlorophenyl)-1-phenylpyrazoline Phenyl 
9 IIA3 methylsulfonyl (4-bromophenyl)-1-phenylpyrazoline Phenyl 
10 IIA4 methylsulfonyl 5-(4-methoxyphenyl)-1-phenylpyrazoline Phenyl 
11 IIA5 methylsulfonyl 5-(4-dimethyaminophenyl)-1-
phenylpyrazoline  
Phenyl 
12 IIA10 Tosyl (5-(4-methoxyphenyl)-1-
phenylpyrazoline 
Phenyl 
13 IIB2 methylsulfonyl 4-(4-chlorophenyl)pyrimidin-2-amine Phenyl 
14 IIB3 methylsulfonyl 4-(4-bromophenyl)pyrimidin-2-amine Phenyl 
15 IIB4 methylsulfonyl 4-(4-methoxyphenyl)pyrimidin-2-amine Phenyl 
16 IIB5 methylsulfonyl 4-(4-(dimethylamino)phenyl)pyrimidin-
2-amine 
Phenyl 
17 IIB7 Tosyl 4-phenylpyrimidin-2-amine Phenyl 
18 IIIA4 H Phenyl 3-(4-hydroxyphenyl)-1-
phenylpyrazoline 
19 IIIA10 H 4-chlorophenyl 3-(4-hydroxyphenyl)-1-
phenylpyrazoline 
20 IIIA11 H 4-chlorophenyl 3-(4-aminophenyl)-1-
phenylpyrazoline 
21 IIIA17 H 4-methoxyphenyl 3-(4-aminophenyl)-1-
phenylpyrazoline 
22 IIIB10 H 4-chlorophenyl 4-(2-amino)pyrimidin-4-yl)phenol 
23 IIIB11 H 4-chlorophenyl 4-(4-aminophenyl)pyrimidin-2-
amine 
24 IIIB17 H 4-methoxyphenyl 4-(4-aminophenyl)pyrimidin-2-
amine 
 
Various approaches for the development of COX-2 inhibitors have 
appeared in the literature over the past several years. The methods 
employed include 3D QSAR studies such as comparative molecular 
field analysis (CoMFA), receptor surface analysis (RSA), kNN method. 
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All models reported are of sufficiently high quality to be used as an 
estimator of the biological activity of unknown compounds; however, 
each model has some limitations. We attempted to obtain further 
insights into the structural requirement of a diarylindole class of COX-
2 inhibitors by the application of 3D-QSAR using kNN-MFA method. 
Molecular alignment was performed which is useful for studying 
shape variation with respect to the base structure selected for 
alignment. Further, the aligned molecules were used for 3D QSAR 
studies. The method used for alignment was Template based. A 
template structure was defined and used as a basis for alignment of a 
set of molecules. The geometries of the aligned molecules were stored 
in the Align Molecules subfolder in the Align folder. All the aligned 
molecules were opened from Align Molecules subfolder in the Align 
folder. The 24 aligned molecules are shown in fig. 1. 
  
 
Fig. 1: Template-based alignment of 24 molecules 
 
Calculation of descriptors for 3D QSAR 
The 3D QSAR worksheet was launched at the beginning. The 
subfolder containing all aligned molecules was opened. The data of 
biological activity (IC50) was inserted in the column. This was 
followed by the calculation of the molecular local shape field 
descriptors for finding a relationship with the activity and various 
parameters for field calculation selected are shown below. 
Field Type: Electrostatic, Steric, and Hydrophobicity 
Charge Type: Gasteiger-Marsili' 
This resulted in the worksheet with 2080 field descriptors (1040 for 
each electrostatic and steric). For performing a robust QSAR 
analysis, descriptors that show variation for all the molecules are 
important. A descriptor that is constant for all the molecules will not 
contribute to QSAR and hence should be removed from the 
worksheet. Thus invariable columns were removed. The training 
and test set was selected by manual selection method ensuring that 
the molecules have uniform spread (training and test) in terms of 
both activity and chemical space. The dependent variable selected 
was biological activity as a negative log of IC50 and the remaining 
variables considered as independent variables. 
The kNN-MFA model was generated using stepwise forward-
backward variable selection method. Stepwise Parameter Settings 
was done as follows:  
Cross-Correlation Limit: 0.5 
Number of Variable in Final Equation: 4 
Term Selection Criteria: q2 
F test In: 4 
F test Out: 3.99  
Variance Cut-Off: 0 kcal/mol A °  
Scaling: Auto Scaling 
The relative positions of the local fields around aligned molecules 
that are important for activity variation in the model were observed 
by clicking the Show Points button in the ‘Model Summary’ dialog 
box. The best model was selected on the basis of various statistical 
parameters. The quality and predictability of the model was 
estimated from the cross-validated squared correlation coefficient 
and predicted r2. 
Docking study  
Molecular docking techniques consist in finding the low-energy 
binding modes of a ligand within the active site of a macromolecule 
and evaluating the binding energy with a score [18]. Explanation of 
the selectivity of small sets of ligands has been attempted with 
accurate but time-consuming techniques [19-21]. Otherwise, 
automated docking methods may be used to estimate the COX-2 
affinity for large molecular databases. The objective of this work had 
been to use structural information of the target to further confirm 
the binding affinity of synthesized molecules to COX-2 enzyme as 
well as study binding nature. 
Optimization of protein 
Docking studies were carried out in Vlife molecular docking suite 3.5 
by using Biopredicta. All the molecular modeling studies were 
performed on Pentium Core2Duo workstation using Sybyl. Docking 
studies were carried out using COX-2 (PROSTAGLANDIN 
SYNTHASE-2; EC: 1.14.99.1) complexed with a selective inhibitor, 
SC-558 (1-phenylsulphonamide-3-trifluoromethyl-5-
bromophenylpyrazole). The 1CX2 isoform of human cyclooxygenase 
was downloaded from Protein Data Bank website. The tetramer is 
converted into the monomer. Water molecules, cofactors, and heme 
were deleted from protein. The SC558 reference molecule was 
extracted. The bond order, bond angle, peptide bond check 
performed using the local geometry check option from the analyze 
menu of the BioPredicta module. Hydrogens were added in molecule 
and energy minimized using Merck Molecular Force Field (MMFF). 
Optimization of ligand 
The structures of SC558 and all the compounds used in COX-2 enzyme in 
vitro assay were energy minimized using MMFF until the root mean 
square gradient values became smaller than 0.0001 kcal/mol A °. 
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Fig. 2: 1cx2 enzyme structure 
 
 
Fig. 3: Co crystalized ligand SC 558 
 
Docking  
Grid docking: This docking method can be used to dock a single 
ligand or its conformer with a given receptor. Cavity Number 2 in 
the Grid Over panel for the 1CX2 receptor selected where the 
docking would be performed. The default grid size was 
automatically chosen by VLife Molecular Design Suite. Rotation 
angle for ligand rotation step size set as 100. Fitness Function 
selected as Dock Score and No of bump allowed as 4. 
Cavity 2 in 1CX2 (protein and co-crystallized ligand) is the cavity 
where the co-crystallized ligand is located. This can be ascertained 
by using the Edit BioPolymer tool. Grid Docking was started. The 
start and progress of the grid docking process at different grid 
points in the cavity (docking site is chosen) was observed in the 
Output Window. On completion of the docking, the final minimum 
score (dock score interaction/docking energy of receptor-ligand) for 
the best ligand pose is displayed in the output window together with 
the location path of the docked receptor-ligand complex. Grid-based 
docking performed in cavity number 2 with a number of bump 4 and 
rotation angle 100 °. Docking scores were recorded. After merging 
and energy minimization the amino acid interactions were analyzed. 
 








Fig. 4: Reference ligand SC 558 
  
Table 2: In vitro COX-inhibition data of compounds 
S. No. Compound COX-1a (IC 50, µM) COX-2 (IC 50, µM) COX-2 SI b (Selectivity Index) 
01 Celecoxib 28.6 0.09 317.77 
02 IA7  37.8 2.2 17.18 
03 IA9  51.2 3.7 13.83 
04 IA11  46.8 3.2 14.62 
05 IA12  49.6 2.8 17.71 
06 IB3 48.1 3.6 13.36 
07 IB7  51.5 3.1 16.61 
08 IB12  45.6 2.4 19 
09 IIA2 39.5 0.91 43.40 
10 IIA3 48.6 0.89 54.60 
11 IIA4 54.1 1.1 49.18 
12 IIA5 47.8 1.3 36.76 
13 IIA10 56.9 1.8 31.61 
14 IIB2 49.9 0.88 56.70 
15 IIB3 48.6 1.2 40.5 
16 IIB4 53.6 1.02 52.54 
17 IIB5 57.5 1.3 44.23 
18 IIB7 52.8 1.9 27.78 
19 IIIA10 44.6 3.1 14.38 
20 IIIA11 48.1 3.9 12.33 
21 IIIA17 50.6 2.6 19.46 
22 IIIA4 49.1 3.4 14.44 
23 IIIB10 39.6 2.3 17.21 
24 IIIB11 47.6 1.6 29.75 
25 IIIB17 38.8 1.1 35.27 
aValues are means of two determinations acquired using an ovine COX-1/COX-2 assay kit and the deviation from the mean is<10% of the mean 
value, bIn vitro COX-2 selectivity index (COX-1 IC50/COX-2 IC50). 
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RESULTS AND DISCUSSION 
The results of in vitro COX inhibition assay on the most active 
twenty-four molecules from all the series shows that these 
compounds are more selective towards COX-2 than COX-1 as shown 
in table 2. Compound IIA3, IIB2, and IIB4 from series II showed 
selectivity index of 54.60, 56.70 and 52.54 respectively for COX-2 vs 
COX-1. The compounds IIIB11 and IIIB17 from series III also showed 
a selectivity index of 29.75 and 35.27 respectively. The remaining 
compounds in series IA, IB, IIIA and IIIB have shown less selectivity 
index as compared to compounds in IIA and IIB series. The results 
show that the presence of the sulfonyl group in series IIA and IIB is 
favorable for maximum drug-receptor interactions. In the 
compounds IIIB11 and IIIB17, the presence of hydrogen bonding 
groups is important for optimum drug-receptor interactions. 
Interpretation of 3D QSAR model  
In the kNN-MFA method, several models were generated for the 
selected members of the training and test set and the corresponding 
best model is reported in table 3. 
  
Table 3: Statistical results of kNN molecular field analysis 
Parameter kNN-MFA method 
N 16 
Degree of freedom 11 
q2 0.9461 
q2_se 0.0493 
Pred r2 0.8782  
pred_r2se 0.1338 
K/Vn 2/4 
Descriptors (range) E_1436 (-1.0557-0.7659) 
S_1207 (-0.1900-0.0832) 
S_720 (-0.7384-0.6306) 
S_832 (30.0000 30.0000) 
 
Results from table 3 show that predictive r2 (Pred_r2) for this model 
is 0.8782 which is considerably high and also other statistical 
parameters are in acceptable range. 
In this model, steric and electrostatic fields’ contribution was found 
to be 75: 25 % respectively. kNN results can be viewed as the stereo 
view of the molecular fields (descriptors) in a rectangular grid 
around the molecular unit as shown around aligned molecules. 
Predictivity of kNN-MFA model 
Predictivity of the model was evaluated by predicting the 
activity of the molecules belonging to the training set (internal 
predictivity) as well as molecules in the test set (external 
predictivity) as shown in tables 4 and 5. Graphical 
representation of the predictive power of the model is shown in 
fig. 5. 
 
Table 4: Observed and predicted IC50 value data for training set compounds (16 molecules) obtained using kNN MFA method 
S. No. Mol. ID. Activity (Observed)* Activity (Predicted)* Residuals 
1 IA7 -0.342423 -0.363355 0.020932 
2 IA11 -0.505150 -0.494736 -0.01041 
3 IB3 -0.556303 -0.474640 -0.08166 
4 IB7 -0.491362 -0.476103 -0.01526 
5 IB12 -0.380211 -0.337445 -0.04277 
6 IIA3 0.050610 -0.029727 0.080337 
7 IIA4 -0.041393 -0.228609 0.187216 
8 IIA5 -0.176091 -0.221712 0.045621 
9 IIA10 -0.255273 -0.249155 -0.00612 
10 IIB4 -0.041393 -0.249983 0.20859 
11 IIB5 -0.113943 -0.060634 -0.05331 
12 IIIA4 -0.531479 -0.476880 -0.0546 
13 IIIA11 -0.591065 -0.468275 -0.12279 
14 IIIA17 -0.414973 -0.372382 -0.04259 
15 IIIB10 -0.361728 -0.352367 -0.00936 
16 IIIB11 -0.462398 -0.426849 -0.03555 
  
Table 5: Observed and predicted IC50 value data for test set compounds (8 molecules) obtained using kNN MFA method 
S. No. Mol. ID. Activity (Observed)* Activity (Predicted)* Residuals 
1 IA9 -0.568202 -0.476102 -0.0921 
2 IA12 -0.447158 -0.528771 0.081613 
3 IIA2 0.040959 -0.013932 0.054891 
4 IIB2 0.055517 0.045140 0.010377 
5 IIB3 -0.079181 0.048473 -0.12765 
6 IIB7 -0.278754 -0.348673 0.069919 
7 IIIA10 -0.491362 -0.468257 -0.02311 
8 IIIB17 -0.322219 -0.358835 0.036616 
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Fig. 5: Plot of observed vs. predicted activity (PIC50)) of the molecules in the training and test set by the stepwise kNN-MFA method 
 
Discussion of stereo view plot of kNN MFA method 
Stereo view of the molecular fields (descriptors) in a rectangular 
grid around the aligned molecules is shown in fig. 6. 
The green spheres show the location where steric contribution has 
played an important role and variation in bulk in that region would 
help in improving the activity. Similarly, blue spheres are the 
locations where electrostatic contribution has played an important 
role and the variation in electronegativity in that region would help 
in improving the activity. The first value in the parenthesis indicates 
the lower limit and the second value is the upper limit of 
steric/electrostatic function values for molecules. The molecule 
adhering to these ranges at respective field locations are likely to be 
in the higher activity range. 
 
 
Fig. 6: Stereoview of the molecular fields (Descriptors) in a rectangular grid around aligned molecules using kNN MFA method 
 
1) Electrostatic field:  
a) Negative range indicates that negative electrostatic potential is 
favorable for an increase in the activity and hence a more 
electronegative substituent group is preferred in the region. 
b) Positive range indicates that positive electrostatic potential is 
favorable for an increase in the activity and hence a less 
electronegative substituent group is preferred in that region.  
2) Steric field:  
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a) Negative range indicates that negative steric potential is favorable 
for an increase in the activity and hence a less bulky substituent 
group is preferred in the region.  
b) Positive range indicates that positive steric potential is favorable 
for an increase in the activity and hence a more bulky substituent 
group is preferred in that region.  
A green sphere (S 832) near the sulfonamide moiety and aryl group 
at 1 position of indole ring, suggests a more bulky group is required 
in this region as indicated by more positive values in the 
paranthesis. Another green sphere (S 720) at the para position of 
aryl ring at 2-position of indole ring, suggests less bulky groups are 
favored for activity in this region. Green sphere (S 1207) at the para 
position on aryl ring at 3-position of indole ring suggests that 
addition of bulk here may decrease the activity as a value in the 
parentheses is more towards the negative side.  
Only one blue sphere (E 1436) is observed in the model near the 
para position of aryl ring at position 1 of the indole nucleus. 
Negative values in the parentheses suggest the more electronegative 
group is favorable in this position. 
Molecules were optimized using MMFF method till gradient 
convergence 0.05 kcal/mol. For viewing the results of docking, 
compound IIIB17 has been selected according to the best-scored 
conformation predicted by the scoring function. The interaction of 
this ligand has been shown in fig. 7. The reference ligand SC558 
docked in cavity 2 of a 1CX2 isoform of the cyclooxygenase enzyme 
is shown in fig. 8. 
 
 
Fig. 7: Docking of reference compound in cavity 2 of the 1CX2 isoform of Cyclooxygenase enzyme 
 
 
Fig. 8: Docking of the most active compound (IIIB17) in cavity 2 of the 1CX2 isoform of Cyclooxygenase enzyme 
Chavan et al. 




Fig. 9: Binding of IIIB17 into the active site of the COX-2 enzyme 
 
The results have been discussed mainly with respect to IIIB17 which 
have better selectivity towards COX-2 enzyme. Hydrogen bonding is 
shown as yellow dotted lines and good contacts as dotted pink lines. 
Good contacts are viewed in 5 A ° area. The best docking pose 
observed for compound IIIB17 was IIIB17_P16 and docking score 
was-14.53 which is comparable to the docking score of original 
ligand-14.98. The lower interaction energy observed for IIIB17 
rationalizes the tighter binding of indole analog. The compound 
IIIB17 was found to be involved in the hydrogen bonding with a 
residue Lys 97. 
 
Table 6: Docking scores of compounds with 1cx2_series A mol 2 receptor 
S. No. Compound  Docking score  Binding energy 
1 SC558 -14.98 -46.2 
2 IIIB17 -14.53 -21.3 
3 IIB2 -14.42 -27.4 
4 IIIB11 -14.3 -12.4 
5 IIA2 -13.81 -51.5 
6 IIB4 -12.7 -24.2 
7 IIA4 -12.43 -13.9 
8 IIB3 -12.4 -16.4 
9 IIA5 -11.33 -24.9 
10 IIB5 -11.12 -39.4 
11 IIA10 -11.12 -10.9 
12 IIB7 -11.11 -16.6 
13 IIA3 -10.02 -22.9 
14 IA7  -10 -17.5 
15 IIIB10 -10.98 -11.5 
16 IB12 -9.88 -12.3 
17 IIIA17 -9.88 -5.6 
18 IA12  -9.76 -4.4 
19 IB7  -8.61 -8.3 
20 IIIA10 -8.59 -15.5 
21 IA11  -7.47 -4 
22 IIIA4 -7.32 -13.4 
23 IB3  -7.26 -14 
24 IA9  -7.06 -19 
25 IIIA11 -6.04 -1.3 
The hydrogen bonding interaction is as follows 
 
S. No. Residue atom Ligand atom  Distance 
1 LYS97A 514N 9059H 1.599 A ° 
2 LYS97A 5044H 9031N 1.792 A ° 
 
The hydrogen bonding distance between NH group of IIIB17 with 
NH of Lysine 97A was found to be 1.599 A ° (N-----H).  
The pyrimidine ring at 3 positions was surrounded by active site 
amino acid residues His 356A, Gly 350A, His 351A, and Asn 581A. 
The indole ring found to interact with residues His 356A, Lysine97A. 
The benzene ring on the pyrimidine nucleus was found to interact 
with Asn581A and Gly 192A. 
Twenty four molecules from six series viz IA, IB, IIA, IIB, IIIA, and 
IIIB were studied by docking with an aim to reveal their binding 
interactions with COX-2 enzyme. Compounds IIIB17, IIIB11 and IIB2 
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shown good docking score comparable to SC558, confirms the 
results obtained through COX inhibition assays. 
CONCLUSION 
The present 3D QSAR study using kNN-MFA method indicated the 
contribution of steric and electronic fields in the activity of 
compounds. The model suggests that a more bulky group is required 
near the sulfonamide moiety/aryl group at 1 position of indole ring, 
as indicated by positive values in the parenthesis and less bulky 
groups are favored for activity at the para position of aryl ring at 2-
position of indole ring while addition of bulk at the para position on 
aryl ring at 3-position of indole ring may decrease the activity. The 
model further suggests that the more electronegative group is 
favorable at the para position of aryl ring at position 1 of the indole 
nucleus. The results of docking studies indicate that the compound 
IIIB17 with highest docking score was found to be involved in the 
hydrogen bonding with a residue Lys 97. The hydrogen bonding 
distance between NH group of IIIB17 with NH of lysine97A was 
found to be 1.599 A ° (N-----H). Thus the results obtained can be 
used for further modification and optimization of the indole 
derivatives for better anti-inflammatory activity with selective COX-
2 inhibition.  
ACKNOWLEDGMENT 
The authors are grateful to Principal Dr. Ashok V. Bhosale for 
providing infrastructure and facilities to conduct the research 
activity. We are also thankful to VLife Sciences for providing 
technical support from time to time.  
AUTHORS CONTRIBUTIONS  
All the authors have contributed equally 
CONFLICTS OF INTERESTS 
All authors have none to declare 
REFERENCES 
1. Gierse JK, McDonald JJ, Scott D, Shaukat H, Koboldt CM, Seibert 
KA. Single amino acid difference between cyclooxygenase-1 
(COX-1) and-2 (COX-2) reverses the selectivity of COX-2 
specific inhibitors. J Biol Chem 1996;271:15810–4. 
2. Maheshwari PPD, Ravichandiran V. Adverse drug reactions and 
interactions of NSAIDs in general care hospital. Asian J Pharma 
Clin Res 2014;7:69-71.  
3. Marnett LJ, Kalgutkar AS. Cyclooxygenase 2 inhibitors: 
discovery selectivity and the future. Trends Pharmacol Sci 
1999;20:465-9. 
4. Ross E. Goodman and gilman’s the pharmacological basis of 
therapeutics. 10th Edition. McGraw-Hill Medical Publishing 
Division; New York; 2000. p. 31-8. 
5. Mahajan A, Sharma R. COX-2 selective nonsteroidal anti-
inflammatory drugs: current status. J Assoc Physicians India 
2005;53:2001-4. 
6. Saxena AK, Ramachandran R, Gulati M, Kumar M. 
Cyclooxygenase-2 inhibitors in postoperative pain and chronic 
pain management: current opinion and future perspective. 
Indian J Anaesth 2005;49:170-9. 
7. Amir M, Dhar N, Tiwari S. Synthesis and anti-inflammatory, 
analgesic, ulcerogenic and lipid peroxidation activities of 3,5-
dimethyl pyrazoles,3-pyrazole-5-ones, and 3,5-disubstituted 
pyrazolines. Indian J Chem Sect B 1997;36B:2532-7. 
8. Barsoum FF, Girgis AS. Facile synthesis of bis (4,5-dihydro-
1Hpyrazole-1-carboxamides) and their thio-analogs of potential 
PGE2 inhibitory properties. Eur J Med Chem 2009;44:2172-7. 
9. Cenicola ML, Donnoli D, Stella L, Paola CD, Constantino M, 
Anignente E, et al. Research on heterocyclic compounds. 
Antiinflammatory activity of some imidazo(1,2-c)pyrimidine 
derivatives. Pharmacol Res 1990;22:80-4.  
10. Nargund LVG, Badiger VV, Yarnal SM. Synthesis and 
antimicrobial and anti-inflammatory activities of substituted 2-
mercapto-3-(n-aryl)pyrimido[5,4-c]cinnolin-4-(3H)-ones. J 
Pharm Sci 1992;81:365-6.  
11. Kalgutkar AS, Marnett AB, Crews BC, Remmel RP, Marnett LJ. 
Ester and amide derivatives of the nonsteroidal anti-
inflammatory drug, indomethacin, as selective COX-2 
inhibitors. J Med Chem 2000;43:2860-70. 
12. Rani P, Srivastava VK, Kumar A. Synthesis and anti-
inflammatory activity of heterocyclic indole derivatives. Eur J 
Med Chem 2004;39:449-52.  
13. Husain A, Ahmad A, Alam MM, Ajmal Mohd, Ahuja P. Fenbufen 
based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-
(biphenyl-4-yl)propan-1-ones as safer anti-inflammatory and 
analgesic agents. Eur J Med Chem 2009;44:3798-804. 
14. Katritzky A. QSAR modeling, synthesis, and bioassay of diverse 
leukemia RPMI-8226 cell line active agents. Bioorg Med Chem 
Lett 2010;45:5183-99. 
15. Rapatri V, Chitre T, Bothara K. Novel 4-(morpholin-4-yl)-N-
(arylidene) benzohydrazides: synthesis, antimycobacterial activity, 
and QSAR investigations. Eur J Med Chem 2009;44:3954-60. 
16. Karthiga Devi S, Velmurugan D. Molecular modelling, QSAR and 
pharmacophore studies on anti-viral, anti-malarial and anti-
inflammatory bioactive compounds from marine sources. Asian 
J Pharma Clin Res 2015;8:36-43.  
17. VLife Molecular Design Suite version 3.5; VLife Sciences 
Technologies Pvt. Ltd., Pune, India; 2010. 
18. Habeeb AG, Parveen PNR, Knaus EE. Design and synthesis of 4, 
5-diphenyl-4-isoxazolines: novel inhibitors of cylooxygenase-2 
with analgesic and anti-inflammatory activity. J Med Chem 
2001;44:2921-7. 
19. Palomer A, Perez JJ, Navea S, Llorens O, Pascual J, Garcia L, et al. 
Modeling cyclooxygenase inhibition: implication of active site 
hydration on the selectivity of ketoprofen analogues. J Med 
Chem 2000;43:2280-4. 
20. Price MLP, Jorgensen WL. Analysis of binding affinities for 
celecoxib analogs with COX-1 and COX-2 from combined 
docking and monte carlo simulations and insight into the COX-
2/COX-1 selectivity. J Am Chem Soc 2000;122:9455-66. 
21. Price MLP, Jorgensen WL. The rationale for the observed COX-
2/COX-1 selectivity of celecoxib from monte carlo simulation. 
Bioorg Med Chem Lett 2001;11:1541-4. 
 
